Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 10/2022

29.08.2022 | Original Article

A Web-Based Prediction Model for Estimating the Probability of Post-hepatectomy Major Complications in Patients with Hepatocellular Carcinoma: A Multicenter Study from a Hepatitis B Virus-Endemic Area

verfasst von: Qing-Yu Kong, Chao Li, Ming-Da Wang, Li-Yang Sun, Jia-Le Pu, Zi-Xiang Chen, Xiao Xu, Yong-Yi Zeng, Zheng-Liang Chen, Ya-Hao Zhou, Ting-Hao Chen, Hong Wang, Hong Zhu, Lan-Qing Yao, Dong-Sheng Huang, Feng Shen, Zhong Chen, Tian Yang

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 10/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The identification of patients at high risk of developing postoperative complications is important to improve surgical safety. We sought to develop an individualized tool to predict post-hepatectomy major complications in hepatitis B virus (HBV)–infected patients with hepatocellular carcinoma (HCC).

Methods

A multicenter database of patients undergoing hepatectomy for HCC were analyzed; 2/3 and 1/3 of patients were assigned to the training and validation cohorts, respectively. Independent risks of postoperative 30-day major complications (Clavien-Dindo grades III–V) were identified and used to construct a web-based prediction model, which predictive accuracy was assessed using C-index and calibration curves, which was further validated by the validation cohort and compared with conventional scores.

Results

Among 2762 patients, 391 (14.2%) developed major complications after hepatectomy. Diabetes mellitus, concurrent hepatitis C virus infection, HCC beyond the Milan criteria, cirrhosis, preoperative HBV-DNA level, albumin-bilirubin (ALBI), and aspartate transaminase to platelet ratio index (APRI) were identified as independent predictors of developing major complications, which were used to construct the online calculator (http://​www.​asapcalculate.​top/​Cal11_​en.​html). This model demonstrated good calibration and discrimination, with the C-indexes of 0.752 and 0.743 in the training and validation cohorts, respectively, which were significantly higher than those conventional scores (the training and validation cohorts: 0.565 ~ 0.650 and 0.568 ~ 0.614, all P < 0.001).

Conclusions

A web-based prediction model was developed to predict the probability of post-hepatectomy major complications in an individual HBV-infected patient with HCC. It can be used easily in the real-world clinical setting to help management-related decision-making and early warning, especially in areas with endemic HBV infection.
Literatur
1.
Zurück zum Zitat Yang JD, Hainaut P, Gores GJ et al. (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16:589-604CrossRef Yang JD, Hainaut P, Gores GJ et al. (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16:589-604CrossRef
2.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394-424CrossRef Bray F, Ferlay J, Soerjomataram I et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394-424CrossRef
3.
Zurück zum Zitat Llovet JM, Kelley RK, Villanueva A et al. (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6CrossRef Llovet JM, Kelley RK, Villanueva A et al. (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6CrossRef
4.
Zurück zum Zitat El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264-1273.e1CrossRef El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264-1273.e1CrossRef
5.
Zurück zum Zitat Huang G, Lai EC, Lau WY et al. (2013) Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg 257:490-505CrossRef Huang G, Lai EC, Lau WY et al. (2013) Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg 257:490-505CrossRef
6.
Zurück zum Zitat Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13:123-135CrossRef Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13:123-135CrossRef
7.
Zurück zum Zitat Zhang B, Zhang B, Zhang Z et al. (2018) 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci 61:660-670CrossRef Zhang B, Zhang B, Zhang Z et al. (2018) 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci 61:660-670CrossRef
8.
Zurück zum Zitat Wang MD, Li C, Liang L et al. (2020) Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma. Oncologist 25:e1541-e1551CrossRef Wang MD, Li C, Liang L et al. (2020) Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma. Oncologist 25:e1541-e1551CrossRef
9.
Zurück zum Zitat El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576CrossRef El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576CrossRef
10.
Zurück zum Zitat Yang T, Zhang J, Lu JH et al. (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073-2082CrossRef Yang T, Zhang J, Lu JH et al. (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073-2082CrossRef
11.
Zurück zum Zitat Colombo M, Sangiovanni A (2003) Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res 60:145-150CrossRef Colombo M, Sangiovanni A (2003) Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res 60:145-150CrossRef
12.
Zurück zum Zitat Rahbari NN, Mehrabi A, Mollberg NM et al. (2011) Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253:453-469CrossRef Rahbari NN, Mehrabi A, Mollberg NM et al. (2011) Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253:453-469CrossRef
13.
Zurück zum Zitat Kamiyama T, Nakanishi K, Yokoo H et al. (2010) Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg 211:443-449CrossRef Kamiyama T, Nakanishi K, Yokoo H et al. (2010) Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg 211:443-449CrossRef
14.
Zurück zum Zitat Shimada M, Takenaka K, Fujiwara Y et al. (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195-198CrossRef Shimada M, Takenaka K, Fujiwara Y et al. (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195-198CrossRef
15.
Zurück zum Zitat Sadamori H, Yagi T, Shinoura S et al. (2013) Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg 100:122-129CrossRef Sadamori H, Yagi T, Shinoura S et al. (2013) Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg 100:122-129CrossRef
16.
Zurück zum Zitat Kusano T, Sasaki A, Kai S et al. (2009) Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Eur J Surg Oncol 35:1179-1185CrossRef Kusano T, Sasaki A, Kai S et al. (2009) Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Eur J Surg Oncol 35:1179-1185CrossRef
17.
Zurück zum Zitat Taketomi A, Kitagawa D, Itoh S et al. (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580-587CrossRef Taketomi A, Kitagawa D, Itoh S et al. (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580-587CrossRef
18.
Zurück zum Zitat Chok KS, Ng KK, Poon RT et al. (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81-87CrossRef Chok KS, Ng KK, Poon RT et al. (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81-87CrossRef
19.
Zurück zum Zitat Doussot A, Lim C, Lahat E et al. (2017) Complications after hepatectomy for hepatocellular carcinoma independently shorten survival: a western, single-center audit. Ann Surg Oncol 24:1569-1578CrossRef Doussot A, Lim C, Lahat E et al. (2017) Complications after hepatectomy for hepatocellular carcinoma independently shorten survival: a western, single-center audit. Ann Surg Oncol 24:1569-1578CrossRef
20.
Zurück zum Zitat Amisaki M, Saito H, Tokuyasu N et al. (2018) Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 17:323-329CrossRef Amisaki M, Saito H, Tokuyasu N et al. (2018) Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 17:323-329CrossRef
21.
Zurück zum Zitat Huang G, Lau WY, Zhou WP et al. (2014) Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis B virus DNA levels and high preoperative hepatitis B surface antigen levels. JAMA Surg 149:519-527CrossRef Huang G, Lau WY, Zhou WP et al. (2014) Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis B virus DNA levels and high preoperative hepatitis B surface antigen levels. JAMA Surg 149:519-527CrossRef
22.
Zurück zum Zitat Li JD, Diao YK, Li J et al. (2021) Association between preoperative prealbumin level and postoperative mortality and morbidity after hepatic resection for hepatocellular carcinoma: a multicenter study from a HBV-endemic area. Am J Surg 221:1024-1032CrossRef Li JD, Diao YK, Li J et al. (2021) Association between preoperative prealbumin level and postoperative mortality and morbidity after hepatic resection for hepatocellular carcinoma: a multicenter study from a HBV-endemic area. Am J Surg 221:1024-1032CrossRef
23.
Zurück zum Zitat Sun LY, Zhu H, Diao YK et al. (2020) A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma. Ann Transl Med 8:1591CrossRef Sun LY, Zhu H, Diao YK et al. (2020) A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma. Ann Transl Med 8:1591CrossRef
24.
Zurück zum Zitat Iasonos A, Schrag D, Raj GV et al. (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364-1370CrossRef Iasonos A, Schrag D, Raj GV et al. (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364-1370CrossRef
25.
Zurück zum Zitat Lei Z, Li J, Wu D et al. (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg 151:356-363CrossRef Lei Z, Li J, Wu D et al. (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg 151:356-363CrossRef
26.
Zurück zum Zitat Johnson PJ, Berhane S, Kagebayashi C et al. (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33:550-558CrossRef Johnson PJ, Berhane S, Kagebayashi C et al. (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33:550-558CrossRef
27.
Zurück zum Zitat Wai CT, Greenson JK, Fontana RJ et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518-526CrossRef Wai CT, Greenson JK, Fontana RJ et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518-526CrossRef
28.
Zurück zum Zitat Yang T, Lin C, Zhai J et al. (2012) Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging. J Cancer Res Clin Oncol 138:1121-1129CrossRef Yang T, Lin C, Zhai J et al. (2012) Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging. J Cancer Res Clin Oncol 138:1121-1129CrossRef
29.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213CrossRef
30.
Zurück zum Zitat Shimizu Y, Sano T, Yasui K (2007) Predicting pleural effusion and ascites following extended hepatectomy in the non-cirrhotic liver. J Gastroenterol Hepatol 22:837-840CrossRef Shimizu Y, Sano T, Yasui K (2007) Predicting pleural effusion and ascites following extended hepatectomy in the non-cirrhotic liver. J Gastroenterol Hepatol 22:837-840CrossRef
31.
Zurück zum Zitat Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313:409-410CrossRef Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313:409-410CrossRef
32.
Zurück zum Zitat Kerr KF, Brown MD, Zhu K et al. (2016) Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol 34:2534-2540CrossRef Kerr KF, Brown MD, Zhu K et al. (2016) Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol 34:2534-2540CrossRef
33.
Zurück zum Zitat Shi JY, Sun LY, Quan B et al. (2021) A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 45:101534CrossRef Shi JY, Sun LY, Quan B et al. (2021) A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 45:101534CrossRef
34.
Zurück zum Zitat Mendes-Braz M, Martins JO (2018) Diabetes mellitus and liver surgery: the effect of diabetes on oxidative stress and inflammation. Mediators Inflamm 2018:2456579CrossRef Mendes-Braz M, Martins JO (2018) Diabetes mellitus and liver surgery: the effect of diabetes on oxidative stress and inflammation. Mediators Inflamm 2018:2456579CrossRef
35.
Zurück zum Zitat Nobili C, Marzano E, Oussoultzoglou E et al. (2012) Multivariate analysis of risk factors for pulmonary complications after hepatic resection. Ann Surg 255:540-550CrossRef Nobili C, Marzano E, Oussoultzoglou E et al. (2012) Multivariate analysis of risk factors for pulmonary complications after hepatic resection. Ann Surg 255:540-550CrossRef
36.
Zurück zum Zitat Li Q, Wang Y, Ma T et al. (2017) Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: a systematic review and meta-analysis. PLoS One 12:e0171129CrossRef Li Q, Wang Y, Ma T et al. (2017) Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: a systematic review and meta-analysis. PLoS One 12:e0171129CrossRef
37.
Zurück zum Zitat Huo TI, Lui WY, Huang YH et al. (2003) Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 98:2293-2298CrossRef Huo TI, Lui WY, Huang YH et al. (2003) Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 98:2293-2298CrossRef
38.
Zurück zum Zitat Yuan HJ, Yuen MF, Ka-Ho Wong D et al. (2005) The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. J Viral Hepat 12:373-379CrossRef Yuan HJ, Yuen MF, Ka-Ho Wong D et al. (2005) The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. J Viral Hepat 12:373-379CrossRef
Metadaten
Titel
A Web-Based Prediction Model for Estimating the Probability of Post-hepatectomy Major Complications in Patients with Hepatocellular Carcinoma: A Multicenter Study from a Hepatitis B Virus-Endemic Area
verfasst von
Qing-Yu Kong
Chao Li
Ming-Da Wang
Li-Yang Sun
Jia-Le Pu
Zi-Xiang Chen
Xiao Xu
Yong-Yi Zeng
Zheng-Liang Chen
Ya-Hao Zhou
Ting-Hao Chen
Hong Wang
Hong Zhu
Lan-Qing Yao
Dong-Sheng Huang
Feng Shen
Zhong Chen
Tian Yang
Publikationsdatum
29.08.2022
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 10/2022
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-022-05435-5

Weitere Artikel der Ausgabe 10/2022

Journal of Gastrointestinal Surgery 10/2022 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.